Bibliography
- Faderl S , O‘BrienS, PuiCHet al. Adult acute lymphoblastic leukemia: concepts and strategies. Cancer 116 , 1165–1176 (2010).
- Marcucci G , HaferlachT, DohnerH. Molecular genetics of adult acute myeloid leukemia: prognostic and therapeutic implications. J. Clin. Oncol.29 , 475–486 (2011).
- Beijnen JH , SchellensJH. Personalized medicine in oncology: a personal view with myths and facts. Curr. Clin. Pharmacol.5 , 141–147 (2010).
- Sharma S , KellyTK, JonesPA. Epigenetics in cancer. Carcinogenesis31 , 27–36 (2010).
- Kulis M , EstellerM. DNA methylation and cancer. Adv. Genet.70 , 27–56 (2010).
- Herranz M , EstellerM. DNA methylation and histone modifications in patients with cancer: potential prognostic and therapeutic targets. Methods Mol. Biol.361 , 25–62 (2007).
- Esteller M , Garcia-FoncillasJ, AndionEet al. Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents. N. Engl. J. Med. 343 , 1350–1354 (2000).
- Weller M , StuppR, ReifenbergerGet al.MGMT promoter methylation in malignant gliomas: ready for personalized medicine? Nat. Rev. Neurol.6 , 39–51 (2010).
- Jabbour E , IssaJP, Garcia-ManeroG, KantarjianH. Evolution of decitabine development: accomplishments, ongoing investigations, and future strategies. Cancer112 , 2341–2351 (2008).
- Chim CS , LauJS, WongKF, KwongYL. CDKN2B methylation is an independent poor prognostic factor in newly diagnosed acute promyelocytic leukemia. Leukemia20 , 149–151 (2006).
- Roman-Gomez J , Jimenez-VelascoA, CastillejoJAet al. Promoter hypermethylation of cancer-related genes: a strong independent prognostic factor in acute lymphoblastic leukemia. Blood 104 , 2492–2498 (2004).
- Irving L , Mainou-FowlerT, ParkerAet al. Methylation markers identify high risk patients in IGHV mutated chronic lymphocytic leukemia. Epigenetics 6 , 300–306 (2011).
- Bullinger L , EhrichM, DohnerKet al. Quantitative DNA methylation predicts survival in adult acute myeloid leukemia. Blood 115 , 636–642 (2010).
- Figueroa ME , LugthartS, LiYet al. DNA methylation signatures identify biologically distinct subtypes in acute myeloid leukemia. Cancer Cell 17 , 13–27 (2010).
- Milani L , LundmarkA, KiialainenAet al. DNA methylation for subtype classification and prediction of treatment outcome in patients with childhood acute lymphoblastic leukemia. Blood 115 , 1214–1225 (2010).
- Nojima M , MaruyamaR, YasuiHet al. Genomic screening for genes silenced by DNA methylation revealed an association between RASD1 inactivation and dexamethasone resistance in multiple myeloma. Clin. Cancer Res. 15 , 4356–4364 (2009).
- Moorman AV , EnsorHM, RichardsSMet al. Prognostic effect of chromosomal abnormalities in childhood B-cell precursor acute lymphoblastic leukaemia: results from the UK Medical Research Council ALL97/99 randomised trial. Lancet Oncol. 11 , 429–438 (2010).
- Palmke N , SantacruzD, WalterJ.Comprehensive analysis of DNA-methylation in mammalian tissues using MeDIP-chip. Methods53 , 175–184 (2011).
- Harris RA , WangT, CoarfaCet al. Comparison of sequencing-based methods to profile DNA methylation and identification of monoallelic epigenetic modifications. Nat. Biotechnol. 28 , 1097–1105 (2010).
- Herman JG , GraffJR, MyohanenS, NelkinBD, BaylinSB. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc. Natl Acad. Sci. USA93 , 9821–9826 (1996).
- Rakyan VK , DownTA, MaslauSet al. Human aging-associated DNA hypermethylation occurs preferentially at bivalent chromatin domains. Genome Res 20 , 434–439 (2010).
- Eads CA , DanenbergKD, KawakamiKet al. MethyLight: a high-throughput assay to measure DNA methylation. Nucleic Acids Res. 28 , E32 (2000).
- Hamburg MA , CollinsFS. The path to personalized medicine. N. Engl. J. Med.363 , 301–304 (2010).
▪ Websites
- Haematology Malignancy Research Network: Details statistics on incidence of hematological malignancies in the UK www.hmrn.org/Statistics/Incidence.aspx
- Treat1000 www.treat1000.org
- MDxHealth (formerly known as OncoMethylome) www.oncomethylome.com
- NCI www.cancer.gov/cancertopics/pdq/treatment/childALL/Health
- Childhood Leukaemia Cell Bank www.cellbank.org.uk
- Section on the Medical Research Council in the UK detailing their translational research strategy www.mrc.ac.uk/Ourresearch/ResearchInitiatives/Translationalresearch
- Section of the NIH website describing their epigenomics program http://commonfund.nih.gov/epigenomics